Natixis’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100
| Closed | -$126 | – | 1099 |
|
|
2024
Q1 | $126 | Sell |
100
-4,900
| -98% | -$6.17K | ﹤0.01% | 954 |
|
|
2023
Q4 | $8.9K | Buy |
+5,000
| New | +$8.9K | ﹤0.01% | 885 |
|
|
2023
Q3 | – | Sell |
-132,000
| Closed | -$264K | – | 1098 |
|
|
2023
Q2 | $264K | Buy |
+132,000
| New | +$264K | ﹤0.01% | 699 |
|